New drug TJ0113 put to the test in healthy volunteers
NCT ID NCT07394452
First seen Feb 06, 2026 · Last updated May 19, 2026 · Updated 11 times
Summary
This early-stage study tested the safety and tolerability of a new drug called TJ0113 in 130 healthy adults. Participants took the drug as a single dose, multiple doses, or after a high-fat meal to see how the body handles it. The goal was to check for side effects and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Zhejiang Xiaoshan hospital
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.